Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2012
Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MSRobert J Fox, Alan Thompson, David Baker, et al.Science Translational Medicine|November 5, 2025
Beyond Alzheimer's disease-translating biomarker insights across CNS diseasesLinda S Brady, Simin Mahinrad, Rebecca M Edelmayer, et al.Nature Reviews. Neurology|July 15, 2022
From the prodromal stage of multiple sclerosis to disease preventionRuth Ann Marrie, Mark Allegretta, Lisa F Barcellos, et al.Multiple Sclerosis and Related Disorders|April 3, 2022
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questionsPaola Zaratin, Patrick Vermersch, Maria Pia Amato, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2021
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposalAlan J Thompson, William Carroll, Olga Ciccarelli, et al.Journal of Participatory Medicine|July 13, 2021
Correction: Data Sharing Goals for Nonprofit Funders of Clinical TrialsTimothy Coetzee, Mad Price Ball, Marc Boutin, et al.Neurology|May 30, 2014
Defining the clinical course of multiple sclerosis: the 2013 revisionsFred D Lublin, Stephen C Reingold, Jeffrey A Cohen, et al.Journal of Participatory Medicine|March 29, 2021
Data Sharing Goals for Nonprofit Funders of Clinical TrialsTimothy Coetzee, Mad Price Ball, Marc Boutin, et al.Multiple Sclerosis and Related Disorders|August 2, 2022
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-βSteve Simpson-Yap, Ashkan Pirmani, Edward De Brouwer, et al.The Lancet. Neurology|December 26, 2017
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J Thompson, Brenda L Banwell, Frederik Barkhof, et al.Pageof 5